A fluorescent benzo[g]isoquinoline-based HIF prolyl hydroxylase inhibitor for cellular imaging
Prolyl hydroxylation domain (PHD) enzymes catalyze the hydroxylation of the transcription factor hypoxia‐inducible factor (HIF) and serve as cellular oxygen sensors. HIF and the PHD enzymes regulate numerous potentially tissue‐protective target genes which can adapt cells to metabolic and ischemic s...
Main Authors: | Mayer, M, Fey, K, Heinze, E, Rainer Wick, C, Abboud, M, Yeh, T, Tumber, A, Orth, N, Schley, G, Buchholz, B, Clark, T, Schofield, C, Willam, C, Burzlaff, N |
---|---|
פורמט: | Journal article |
יצא לאור: |
Wiley
2018
|
פריטים דומים
-
No benefit of HIF prolyl hydroxylase inhibition for hypertensive renal damage in renovascular hypertensive rats
מאת: Andrea Hartner, et al.
יצא לאור: (2023-06-01) -
Tuning the transcriptional response to hypoxia by inhibiting HIF prolyl- and asparaginyl-hydroxylases
מאת: Chan, M, et al.
יצא לאור: (2016) -
Molecular and Cellular Mechanisms of HIF Prolyl Hydroxylase inhibitors in Clinical Trials
מאת: Yeh, TL, et al.
יצא לאור: (2017) -
The use of dioxygen by HIF prolyl hydroxylase (PHD1).
מאת: McNeill, L, et al.
יצא לאור: (2002) -
2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase.
מאת: Mole, D, et al.
יצא לאור: (2003)